Create your Customized Agenda!
A Day by Day Guide:
Monday, May 4 - Focused Discussion Day
Mechanistic Science Deep Dives
Workshop A: Epigenetic Mechanisms Governing Liver Fibrogenesis in NASH
Workshop B: Inflammation & Inflammasome Modulation to Treat NASH & Liver Fibrosis
New to NASH
Workshop C: Assessing the Translational Relevance & Robustness of Preclinical Modalities
Workshop D: Getting to Grips with the Non-Invasive Evaluation of NAFLD & NASH
Further than NASH
Workshop E: Understanding Hepatocellular Carcinoma as an Extension of NASH Cirrhosis (Including Keynote Speakers)
Workshops
Workshop G: Drug Safety in NASH: Drugging an Impaired Liver
Workshop H: Pediatric NAFLD/ NASH Drug Development: Regulatory Guidelines, Challenges& Opportunities
Tuesday, May 5 - Scientific Program Day 1
Plenary Stream
Discovery Science Stream
Plenary Stream
Plenary Stream
Translational Drug Development Stream
Plenary Stream
Plenary Stream
Non-Invasive Biomarkers Stream
Plenary Stream
Plenary Stream
Clinical Drug Development Stream
Plenary Stream
Wednesday, May 6 - Scientific Program Day 2
Plenary Stream
Discovery Science Stream
Plenary Stream
Plenary Stream
Translational Drug Development Stream
Plenary Stream
Plenary Stream
Non-Invasive Biomarkers Stream
Plenary Stream
Plenary Stream
Clinical Drug Development Stream
Plenary Stream
Thursday, May 7 - Forward Thinking Seminar Day
Further than NASH
Full Day Seminar A: NASH & Wider Fibrosis Seminar - Overlap and relationships across organ-specific pathological fibrosis, and lessons learned from other fibrotic disease clinical drug development and regulatory intelligence
Next Steps
Full Day Seminar B: Uptake of Drugs to Market Seminar - Understanding key considerations from pharma and payers, and evaluating consequences of change to market opportunity and access for NASH